Rockefeller Capital Management
CALC icon

Rockefeller Capital Management’s CalciMedica CALC Stock Holding History

Rockefeller Capital Management’s Portfolio CALC Stock Details CALC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.6K Buy
4,000
+3,000
+300% +$10.6K ﹤0.01% 3720
2026
Q1 		$2.7K Sell
1,000
-1,000
-50% -$10.1K ﹤0.01% 4361
2025
Q4 		$65.9K Hold
2,000
– – ﹤0.01% 2938
2025
Q3 		$30.8K Buy
+2,000
New +$28.8K ﹤0.01% 3138

Other funds holding CALC

WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
SC
Stempoint Capital New York $581M AUM 373.68% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
LGM
L1 Global Manager Melbourne $142M AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Rockefeller Capital Management's CALC Position: Q2 2026 in Review

Rockefeller Capital Management increased its CalciMedica (CALC) stake by 300% in Q2 2026, buying an estimated $10.6K and bringing the position to 4,000 shares worth $20.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3720.

Rockefeller Capital Management first reported a position in CALC in Q3 2025 and has held it in 4 quarters since. The position peaked at $65.9K in Q4 2025. 31 funds tracked by Wall St. Rank hold CALC as of Q2 2026.

  • Rockefeller Capital Management held 4,000 shares of CalciMedica worth $20.6K as of Q2 2026.
  • Rockefeller Capital Management bought 3,000 CalciMedica shares in Q2 2026, an estimated $10.6K.
  • CalciMedica made up ﹤0.01% of Rockefeller Capital Management's portfolio in Q2 2026, its #3720 holding.
  • Rockefeller Capital Management first reported a position in CalciMedica in Q3 2025 and has held it in 4 quarters since.
  • Rockefeller Capital Management's CalciMedica position peaked at $65.9K in Q4 2025.
  • 31 funds tracked by Wall St. Rank held CalciMedica as of Q2 2026.

Based on Rockefeller Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.